2026 Changes

Business

Financial Institutions Caps 'Strong' 2025 with Robust Earnings, Eyes Growth from Micron-Led Upstate NY Boom

Financial Institutions (FISI) reported solid Q4 and full-year 2025 results, beating guidance on key profitability metrics. Management highlighted disciplined loan growth, a strengthened capital position, and strategic shifts, while pointing to long-term opportunities from major industrial investments in its Upstate New York footprint.

Jan 30, 2026

Business

Minerals 260's Valuation in Focus After Bullabulling Gold Resource Boost to 4.5M Ounces

Minerals 260 (ASX:MI6) has significantly upgraded the resource estimate at its flagship Bullabulling gold project to 4.5 million ounces, sparking renewed investor interest. Despite recent share price volatility, the long-term outlook appears buoyed by upcoming study milestones and a substantial intrinsic value gap, raising questions about whether the market is undervaluing its potential.

Jan 30, 2026

Business

Drax Inks Major 10-Year Deal to Bolster UK Grid with 250MW Battery Storage

Energy giant Drax has secured a decade-long tolling agreement with Fidra Energy for a new 250MW battery storage system in Nottinghamshire, marking a capital-light expansion of its flexible generation portfolio as the UK races to decarbonise.

Jan 30, 2026

Business

Analysts Revise Target for Invesco Mortgage Capital, Signaling Shift in Market Sentiment

A revised price target for Invesco Mortgage Capital (IVR) is prompting investors to reassess the mortgage REIT's trajectory amid evolving interest rate expectations and housing market dynamics.

Jan 30, 2026

Business

Bitmine's Leadership Shakeup and Massive Ethereum Bet Raise Investor Concerns

Bitmine Immersion Technologies faces heightened scrutiny following the sudden departure of its president and a strategic pivot that has seen it amass over 3.5% of all Ethereum. Analysts question the dual risks of management instability and extreme asset concentration as the stock shows recent volatility.

Jan 30, 2026

Business

Nutrien's 31% Surge: Is the Rally Justified or Has the Train Left the Station?

Nutrien Ltd. (TSX:NTR) shares have climbed over 31% in the past year, prompting investors to question if the agricultural giant still presents a buying opportunity. A deep dive into valuation metrics suggests the stock may be fairly priced, but diverging narratives on future growth leave room for debate.

Jan 30, 2026

Business

Aon Caps Off Strategic Three-Year Plan with Strong 2025, Eyes Data Center Boom and $7B War Chest for Growth

The global professional services firm reported 6% organic revenue growth for the second consecutive year, fueled by its Aon United strategy and strategic acquisitions like NFP. With $7 billion in available capital, Aon is poised to accelerate investments in high-growth areas, notably the burgeoning data center and alternative capital markets.

Jan 30, 2026

Business

Quarterhill's Five-Year Plunge: A 66% Loss Tests Investor Patience

Quarterhill Inc. (TSE:QTRH) shareholders have endured a punishing five-year period, with the stock's value plummeting nearly 70%. Despite modest revenue growth, the market's verdict has been harsh, raising questions about the company's path to profitability and the perils of long-term bets in turbulent sectors.

Jan 30, 2026

Business

Microsoft's AI Ambitions Face Market Scrutiny as Stock Plunges to 8-Month Low

Despite posting robust quarterly earnings, Microsoft shares tumbled over 10% as investors balked at rising costs and a cautious outlook, raising questions about the sustainability of its AI-driven growth narrative.

Jan 30, 2026

World

Putin Agrees to Temporary Halt on Kyiv Strikes Following Trump Appeal, as Deep Freeze Grips Ukraine

The Kremlin confirmed Friday that President Vladimir Putin has agreed to a week-long pause in strikes on the Ukrainian capital Kyiv, a move initiated by a personal request from U.S. President Donald Trump. The temporary ceasefire, set to expire Sunday, comes amid a brutal cold snap and ahead of a new round of negotiations.

Jan 30, 2026

Business

Truist Stands By DLocal With Price Target Hike, Eyes Strong Q4 Amid Tough Comparisons

Analysts at Truist reaffirm their Buy rating on DLocal (DLO), raising their price target to $17 ahead of the fintech firm's Q4 2025 earnings. While expecting solid results, they flag challenging year-over-year volume comparisons that may cap upside surprises.

Jan 30, 2026

Business

Goldman Sachs Lifts Zeta Global Target to $26, Eyes Software M&A Wave on Horizon

Goldman Sachs raises its price target for Zeta Global (ZETA), citing strategic positioning ahead of an expected surge in software sector mergers and acquisitions driven by valuation gaps and synergy potential.

Jan 30, 2026

Business

Analysts Eye Credo Technology's AI Data Center Role, But Competition Looms

Rosenblatt Securities initiates coverage on Credo Technology with a Neutral rating and a $170 price target, highlighting its strong position in high-speed connectivity for AI infrastructure while flagging competitive pressures. The note follows a more bullish target hike from Barclays earlier in the month.

Jan 30, 2026

Business

Piper Sandler Stays Bullish on AGNC Investment, Sees Opportunity in Narrowing MBS Spreads

Analyst firm Piper Sandler reiterates its Overweight rating on AGNC Investment Corp., highlighting a favorable shift in agency mortgage-backed securities spreads that could bolster the REIT's book value.

Jan 30, 2026

Business

LifeSci Capital Boosts Price Target on Olema Pharmaceuticals, Citing Promising Breast Cancer Drug Pipeline

LifeSci Capital reaffirms its Buy rating on Olema Pharmaceuticals (OLMA) and raises its price target to $45, following bullish analyst sentiment on the company's lead drug candidate, Palazestrant, for ER+/HER2- breast cancer.

Jan 30, 2026

Business

Immunocore Gains Analyst Backing as Late-Stage Trials Loom

Immunocore Holdings (NASDAQ: IMCR) has drawn renewed bullish sentiment from analysts at H.C. Wainwright and UBS, who highlight the stock's potential as key Phase 3 trial data for its cancer immunotherapies approaches later this decade.

Jan 30, 2026

Business

Truist Trims Price Target on Packaging Corp. After Q4 Earnings Shortfall, Maintains Buy Rating

Analysts at Truist Securities have adjusted their outlook for Packaging Corporation of America (PKG), lowering the price target to $270 following a fourth-quarter earnings miss. Despite the revision, the firm reiterates its Buy rating, suggesting the recent stock dip may present a strategic buying opportunity ahead of anticipated strength in the packaging sector.

Jan 30, 2026

World

Mozambique Flood Crisis Deepens: UN Warns of Overcrowded Shelters, Pleads for Urgent Aid

As severe flooding displaces hundreds of thousands in Mozambique, the UN raises alarms over dangerously overcrowded temporary shelters and a critical funding shortfall, warning of heightened risks for vulnerable populations.

Jan 30, 2026

Business

Giverny Capital Exits Fiserv Stake, Citing AI Shift and Underperformance

Investment firm Giverny Capital Asset Management detailed its sale of Fiserv shares in its 2025 year-end letter, pointing to market fixation on artificial intelligence and the financial technology giant's steep decline. The move highlights a broader divergence between fundamental performance and current investor sentiment.

Jan 30, 2026

Business

Giverny Capital Exits Longtime Stake in CarMax, Shifts Focus Amid Market's AI Frenzy

Investment firm Giverny Capital has sold its entire position in used-car retailer CarMax, a holding of several years, as detailed in its Q4 2025 investor letter. The move highlights a strategic pivot away from traditional retail plays towards perceived higher-growth opportunities in technology, even as the firm's portfolio underperformed major indices last quarter.

Jan 30, 2026